Skip to main content
. 2016 Jun 10;16:502. doi: 10.1186/s12889-016-3170-2

Table 2.

Odds of having metabolic syndrome according to presence of depressive symptoms and use of antidepressant medications in the Maine-Syracuse Longitudinal Study

Depressive symptoms/medication use Covariate seta Quartile of scoresb MetS
OR 95 % CI P-value
CES-D score Basic Q4 1.79 1.22, 2.62 0.003
Q3 1.35 0.93, 1.97 0.1
Q2 1.05 0.72, 1.54 0.8
Q1 1.00
Extended Q4 1.50 1.00, 2.24 0.049
Q3 1.23 0.83, 1.82 0.3
Q2 0.99 0.66, 1.49 0.9
Q1 1.00
Zung score Basic Q4 1.71 1.17, 2.50 0.006
Q3 1.20 0.81, 1.77 0.4
Q2 1.14 0.79, 1.65 0.5
Q1 1.00
Extended Q4 1.43 0.99, 2.50 0.1
Q3 0.99 0.66, 1.52 0.9
Q2 1.05 0.71, 1.54 0.8
Q1 1.00
Antidepressant medication use Basic Yes 2.31 1.51, 3.54 <0.001
No 1.00
Extended Yes 2.22 1.42, 3.48 <0.001
No 1.00

CES-D Center for Epidemiologic Studies Depression Scale, CI confidence interval, MetS metabolic syndrome, OR odds ratio

aBasic: adjusted for age, education, sex, ethnicity; Extended: adjusted for set 1 + smoking (cigarettes per day), physical activity (MET-minutes/day), CRP (mg/L)

bQuartile 1 (lowest quartile of scores) = reference group